vs

Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Mediaco Holding Inc. (MDIA). Click either name above to swap in a different company.

Mediaco Holding Inc. is the larger business by last-quarter revenue ($38.7M vs $38.3M, roughly 1.0× ImmunityBio, Inc.). Mediaco Holding Inc. runs the higher net margin — -83.6% vs -161.8%, a 78.2% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 17.9%). Mediaco Holding Inc. produced more free cash flow last quarter ($-460.0K vs $-71.3M).

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

MediaCo Holding Inc. is an American media company with offices based in Burbank, California and New York City, owned by private equity firms HPS Investment Partners, LLC and Standard General. MediaCo caters to the African-American and the Spanish-speaking Hispanic communities. The company owns television and radio stations in several of the top multicultural markets, and is the parent company of the Estrella TV network.

IBRX vs MDIA — Head-to-Head

Bigger by revenue
MDIA
MDIA
1.0× larger
MDIA
$38.7M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+389.1% gap
IBRX
407.0%
17.9%
MDIA
Higher net margin
MDIA
MDIA
78.2% more per $
MDIA
-83.6%
-161.8%
IBRX
More free cash flow
MDIA
MDIA
$70.8M more FCF
MDIA
$-460.0K
$-71.3M
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IBRX
IBRX
MDIA
MDIA
Revenue
$38.3M
$38.7M
Net Profit
$-61.9M
$-32.3M
Gross Margin
99.0%
Operating Margin
-169.0%
-16.0%
Net Margin
-161.8%
-83.6%
Revenue YoY
407.0%
17.9%
Net Profit YoY
-4.7%
-661.9%
EPS (diluted)
$-0.06
$-0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBRX
IBRX
MDIA
MDIA
Q4 25
$38.3M
$38.7M
Q3 25
$32.1M
$35.4M
Q2 25
$26.4M
$31.2M
Q1 25
$16.5M
$28.0M
Q4 24
$7.6M
$32.8M
Q3 24
$6.1M
$29.9M
Q2 24
$26.2M
Q1 24
$6.7M
Net Profit
IBRX
IBRX
MDIA
MDIA
Q4 25
$-61.9M
$-32.3M
Q3 25
$-67.3M
$-17.9M
Q2 25
$-92.6M
$-7.4M
Q1 25
$-129.6M
$-8.6M
Q4 24
$-59.2M
$-4.2M
Q3 24
$-85.7M
$54.9M
Q2 24
$-48.3M
Q1 24
$-3.7M
Gross Margin
IBRX
IBRX
MDIA
MDIA
Q4 25
99.0%
Q3 25
99.4%
Q2 25
99.5%
Q1 25
99.6%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
IBRX
IBRX
MDIA
MDIA
Q4 25
-169.0%
-16.0%
Q3 25
-173.5%
-20.0%
Q2 25
-269.8%
-21.7%
Q1 25
-390.1%
-16.7%
Q4 24
-919.0%
-13.8%
Q3 24
-1314.3%
-23.0%
Q2 24
-50.9%
Q1 24
-51.7%
Net Margin
IBRX
IBRX
MDIA
MDIA
Q4 25
-161.8%
-83.6%
Q3 25
-209.8%
-50.5%
Q2 25
-350.3%
-23.7%
Q1 25
-784.9%
-30.7%
Q4 24
-783.4%
-12.9%
Q3 24
-1404.0%
184.0%
Q2 24
-184.4%
Q1 24
-54.8%
EPS (diluted)
IBRX
IBRX
MDIA
MDIA
Q4 25
$-0.06
$-0.39
Q3 25
$-0.07
$-0.22
Q2 25
$-0.10
$-0.11
Q1 25
$-0.15
$-0.12
Q4 24
$-0.08
$0.19
Q3 24
$-0.14
$0.66
Q2 24
$-0.75
Q1 24
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBRX
IBRX
MDIA
MDIA
Cash + ST InvestmentsLiquidity on hand
$242.8M
$5.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-500.5M
$46.3M
Total Assets
$501.9M
$291.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBRX
IBRX
MDIA
MDIA
Q4 25
$242.8M
$5.1M
Q3 25
$257.8M
$6.2M
Q2 25
$153.7M
$2.9M
Q1 25
$61.6M
$6.3M
Q4 24
$149.8M
$4.4M
Q3 24
$130.4M
$7.7M
Q2 24
$9.9M
Q1 24
$4.0M
Stockholders' Equity
IBRX
IBRX
MDIA
MDIA
Q4 25
$-500.5M
$46.3M
Q3 25
$-524.3M
$86.7M
Q2 25
$-570.7M
$97.3M
Q1 25
$-591.4M
$85.5M
Q4 24
$-489.1M
$62.1M
Q3 24
$-745.1M
$67.9M
Q2 24
$13.7M
Q1 24
$33.3M
Total Assets
IBRX
IBRX
MDIA
MDIA
Q4 25
$501.9M
$291.1M
Q3 25
$519.0M
$319.4M
Q2 25
$402.1M
$315.1M
Q1 25
$303.8M
$317.7M
Q4 24
$382.9M
$325.5M
Q3 24
$364.6M
$338.4M
Q2 24
$338.6M
Q1 24
$325.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBRX
IBRX
MDIA
MDIA
Operating Cash FlowLast quarter
$-70.4M
$32.0K
Free Cash FlowOCF − Capex
$-71.3M
$-460.0K
FCF MarginFCF / Revenue
-186.2%
-1.2%
Capex IntensityCapex / Revenue
2.4%
1.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-308.8M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBRX
IBRX
MDIA
MDIA
Q4 25
$-70.4M
$32.0K
Q3 25
$-68.9M
$2.8M
Q2 25
$-79.7M
$-3.0M
Q1 25
$-85.9M
$2.1M
Q4 24
$-85.1M
$10.9M
Q3 24
$-98.8M
$-6.0M
Q2 24
$-25.1M
Q1 24
$412.0K
Free Cash Flow
IBRX
IBRX
MDIA
MDIA
Q4 25
$-71.3M
$-460.0K
Q3 25
$-69.6M
$2.8M
Q2 25
$-80.8M
$-3.2M
Q1 25
$-87.0M
$2.0M
Q4 24
$-87.3M
$10.5M
Q3 24
$-101.6M
$-6.6M
Q2 24
$-25.2M
Q1 24
$386.0K
FCF Margin
IBRX
IBRX
MDIA
MDIA
Q4 25
-186.2%
-1.2%
Q3 25
-217.2%
8.0%
Q2 25
-305.9%
-10.2%
Q1 25
-526.9%
7.1%
Q4 24
-1155.4%
31.9%
Q3 24
-1663.2%
-22.2%
Q2 24
-96.1%
Q1 24
5.8%
Capex Intensity
IBRX
IBRX
MDIA
MDIA
Q4 25
2.4%
1.3%
Q3 25
2.3%
0.0%
Q2 25
4.1%
0.7%
Q1 25
6.8%
0.2%
Q4 24
28.0%
1.2%
Q3 24
45.7%
2.1%
Q2 24
0.3%
Q1 24
0.4%
Cash Conversion
IBRX
IBRX
MDIA
MDIA
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.11×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBRX
IBRX

Segment breakdown not available.

MDIA
MDIA

Video Segment$26.4M68%
Advertising$10.0M26%
Other$1.7M4%
Service Other$536.0K1%

Related Comparisons